Therapeutic drug monitoring in inflammatory bowel disease
about
Predicting durable response or resistance to antitumor necrosis factor therapy in inflammatory bowel diseaseCurrent stage in inflammatory bowel disease: What is next?Pharmacologic therapy for inflammatory bowel disease refractory to steroidsThe Anti-Inflammatory Effect of Guchangzhixie-Pill by Reducing Colonic EC Cell Hyperplasia and Serotonin Availability in an Ulcerative Colitis Rat Model.Loss of Response to Anti-TNFs: Definition, Epidemiology, and Management.New Trends in Inflammatory Bowel Disease.
P2860
Therapeutic drug monitoring in inflammatory bowel disease
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Therapeutic drug monitoring in inflammatory bowel disease
@ast
Therapeutic drug monitoring in inflammatory bowel disease
@en
Therapeutic drug monitoring in inflammatory bowel disease
@nl
type
label
Therapeutic drug monitoring in inflammatory bowel disease
@ast
Therapeutic drug monitoring in inflammatory bowel disease
@en
Therapeutic drug monitoring in inflammatory bowel disease
@nl
prefLabel
Therapeutic drug monitoring in inflammatory bowel disease
@ast
Therapeutic drug monitoring in inflammatory bowel disease
@en
Therapeutic drug monitoring in inflammatory bowel disease
@nl
P2860
P1476
Therapeutic drug monitoring in inflammatory bowel disease
@en
P2093
Ernest Seidman
Shomron Ben-Horin
P2860
P304
P50
P577
2014-01-01T00:00:00Z